bioHalosis Overview
- Year Founded
-
2022
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
bioHalosis General Information
Description
Provider of chromatin analysis services intended to identify proteins that bind to specific deoxyribonucleic acid elements. The company offers a patented plasmid pull-down approach, a triple-helix molecular probe, mass spectrometry, a proprietary protein isolation methodology, and chromatin exploration capabilities, enabling biotechnology and pharmaceutical companies to identify proteins interacting with targeted sequences and discover new pharmacological targets.
Contact Information
Website
www.biohalosis.comCorporate Office
- 49 Rue Jules Isaac
- 13009 Marseille
- France
Corporate Office
- 49 Rue Jules Isaac
- 13009 Marseille
- France
bioHalosis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 26-Oct-2022 | Completed | Startup |
bioHalosis Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Incubateur Impulse | Accelerator/Incubator |
bioHalosis FAQs
-
When was bioHalosis founded?
bioHalosis was founded in 2022.
-
Where is bioHalosis headquartered?
bioHalosis is headquartered in Marseille, France.
-
What industry is bioHalosis in?
bioHalosis’s primary industry is Biotechnology.
-
Is bioHalosis a private or public company?
bioHalosis is a Private company.
-
What is bioHalosis’s current revenue?
The current revenue for bioHalosis is .
-
Who are bioHalosis’s investors?
Incubateur Impulse has invested in bioHalosis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process